Financial Toxicity as an End Point in Prospective Clinical Trials Involving Radiation Therapy.

Prasad, Rahul N; Royce, Trevor J; Chino, Fumiko; Jagsi, Reshma; Palmer, Joshua D

Prasad, Rahul N; Royce, Trevor J; Chino, Fumiko; Jagsi, Reshma; Palmer, Joshua D.

Afiliação

Prasad RN; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Royce TJ; Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Chino F; Flatiron Health, New York, New York.
Jagsi R; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Palmer JD; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

Adv Radiat Oncol ; 7(6): 100970, 2022.

Article em En | MEDLINE | ID: mdl-35620674

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Adv Radiat Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google